Rua Life Sciences PLC
LSE:RUA

Watchlist Manager
Rua Life Sciences PLC Logo
Rua Life Sciences PLC
LSE:RUA
Watchlist
Price: 12.5 GBX -3.85%
Market Cap: 7.8m GBX
Have any thoughts about
Rua Life Sciences PLC?
Write Note
Section:
 

Relative Value

RUA doesn't have a meaningful market cap.

The Relative Value of one RUA stock under the Base Case scenario is 10 GBX. Compared to the current market price of 12.5 GBX, Rua Life Sciences PLC is Overvalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RUA Relative Value
Base Case
10 GBX
Overvaluation 20%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.5
P/S
P/S
Price to Sales
3.5
vs History
41
vs Industry
34
Median 3Y
3.7
Median 5Y
3
Industry
2.3
Forward
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-5.7
Industry
23
Forward
-7.6
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-5
Median 5Y
-6.5
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-5.8
Industry
20
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
71
vs Industry
46
Median 3Y
1.2
Median 5Y
1.7
Industry
2.2
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
42
vs Industry
32
Median 3Y
2.6
Median 5Y
1.4
Industry
2.4
Forward
1.2
More Details
2.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.3
vs History
42
vs Industry
48
Median 3Y
3.1
Median 5Y
1.7
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-4.1
Industry
12.9
Forward
-5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-3.5
Industry
17.4
Forward
-3.6
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-5.5
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-4
Industry
18.2
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
71
vs Industry
44
Median 3Y
1.2
Median 5Y
1.9
Industry
1.9
More Details

Multiples Across Competitors

RUA Competitors Multiples
Rua Life Sciences PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Rua Life Sciences PLC
LSE:RUA
7.8m GBP 3.5 -5.4 -2.6 -2.1
JP
Hoya Corp
TSE:7741
7.1T JPY 8.5 35.6 23.9 28.8
CH
Alcon AG
SIX:ALC
37.9B CHF 4.2 35.7 17.6 34.1
DK
Coloplast A/S
CSE:COLO B
179B DKK 6.6 35.5 22.8 26.8
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD 4.1 36.4 18.4 22.1
KR
HLB Inc
KOSDAQ:028300
10.5T KRW 202.1 -56.5 -87 -82.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.1B CNY 11.5 27.6 24 24
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.6 12
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 56
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.6 23.7 38.9
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.2 264.5 462.1
P/E Multiple
Earnings Growth PEG
UK
Rua Life Sciences PLC
LSE:RUA
Average P/E: 33.9
Negative Multiple: -5.4 		N/A N/A
JP
Hoya Corp
TSE:7741
35.6
15%
2.4
CH
Alcon AG
SIX:ALC
35.7
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.5
15%
2.4
US
Align Technology Inc
NASDAQ:ALGN
36.4
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -56.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.3
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.3 N/A N/A
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.6
37%
1.3
UK
ConvaTec Group PLC
LSE:CTEC
37.2
46%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Rua Life Sciences PLC
LSE:RUA
Average EV/EBITDA: 46.9
Negative Multiple: -2.6 		N/A N/A
JP
Hoya Corp
TSE:7741
23.9
15%
1.6
CH
Alcon AG
SIX:ALC
17.6
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.8
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.4
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -87 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.6
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
22%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.7
22%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
264.5
12%
22
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Rua Life Sciences PLC
LSE:RUA
Average EV/EBIT: 78.3
Negative Multiple: -2.1 		N/A N/A
JP
Hoya Corp
TSE:7741
28.8
N/A N/A
CH
Alcon AG
SIX:ALC
34.1
27%
1.3
DK
Coloplast A/S
CSE:COLO B
26.8
12%
2.2
US
Align Technology Inc
NASDAQ:ALGN
22.1
17%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -82.1 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24
23%
1
US
Lantheus Holdings Inc
NASDAQ:LNTH
12
12%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
56
56%
1
US
Merit Medical Systems Inc
NASDAQ:MMSI
38.9
36%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
462.1
25%
18.5

See Also

Summary
RUA intrinsic value, competitors valuation, and company profile.
DCF Valuation
RUA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RUA stock valuation using valuation multiples.
Wall Street Estimates
RUA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RUA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.